gbr 12935 has been researched along with Depressive Disorder in 1 studies
1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine : An N-alkylpiperazine that consists of piperazine bearing 2-(benzhydryloxy)ethyl and 3-phenylpropyl groups at positions 1 and 4 respectively. Potent and selective inhibitor of dopamine uptake (KD = 5.5 nM in rat striatal membranes).
Depressive Disorder: An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowden, C | 1 |
| Cheetham, SC | 1 |
| Lowther, S | 1 |
| Katona, CL | 1 |
| Crompton, MR | 1 |
| Horton, RW | 1 |
1 other study available for gbr 12935 and Depressive Disorder
| Article | Year |
|---|---|
Dopamine uptake sites, labelled with [3H]GBR12935, in brain samples from depressed suicides and controls.
Topics: Adolescent; Adult; Aged; Brain; Caudate Nucleus; Depressive Disorder; Dopamine; Dopamine Plasma Memb | 1997 |